PASW
Ping An Biomedical Co., Ltd.
NASDAQ · Industrials · Industrial - Distribution · HK
$5.12
+2.40%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 25.5M | 34.1M | 87.6M | 82.6M | 114.5M |
| Cost of Revenue | 23.1M | 33.2M | 82.2M | 78.3M | 100.4M |
| Gross Profit | 2.4M | 949.5K | 5.4M | 4.2M | 14.1M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 12.9M | 6.3M | 4.8M | 3.2M | 3.1M |
| General & Admin Expense | 7.7M | 6.0M | 4.5M | 2.9M | 2.8M |
| Selling & Marketing Expense | 1.9M | 300.0K | 306.6K | 332.5K | 350.2K |
| Other Expenses | — | 9.3M | 570.6K | 416.8K | 222.4K |
| Total Operating Expenses | 12.9M | 15.7M | 5.4M | 3.6M | 3.3M |
| Cost and Expenses | 36.1M | 48.8M | 87.6M | 82.0M | 103.7M |
| Operating Income (EBIT) | (10.5M) | (14.7M) | (2.0K) | 612.5K | 10.8M |
| Non-Operating | |||||
| Interest Income | — | 326.3K | 2.0K | 156.1K | 42.3K |
| Interest Expense | — | 307.1K | 705.3K | 1.7M | 1.6M |
| Net Interest Income | 106.6K | 19.3K | (703.2K) | (1.6M) | (1.5M) |
| Other Non-Op Income/Expense | 5.9M | 16.7K | (680.7K) | (570.8K) | (1.2M) |
| Non-Operating Income (excl Interest) | — | (323.7K) | (24.6K) | (1.2M) | (376.4K) |
| EBT (Pre-Tax Income) | (4.7M) | (14.7M) | (682.7K) | 41.7K | 9.6M |
| Income Tax Expense | 3.8M | (1.9M) | 601.5K | 1.0M | 2.4M |
| Bottom Line | |||||
| Net Income | (3.8M) | (12.8M) | (1.3M) | (993.9K) | 7.2M |
| Earnings from Cont. Ops | (3.8M) | (12.8M) | (1.3M) | (993.9K) | 7.2M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (3.8M) | (12.8M) | (1.3M) | (993.9K) | 7.2M |
| Per Share | |||||
| Basic EPS | ($14.58) | ($27.60) | ($2.85) | ($1.94) | $14.00 |
| Diluted EPS | ($14.58) | ($27.60) | ($2.85) | ($1.94) | $14.00 |
| Revenue Per Share | $20.20 | $73.92 | $194.71 | $161.10 | $223.51 |
| Shares | |||||
| Basic Shares Outstanding | 1.3M | 461987 | 450006 | 512500 | 512500 |
| Diluted Shares Outstanding | 1.3M | 461986 | 450000 | 512500 | 512500 |
| Profitability Metrics | |||||
| EBITDA | (10.5M) | (14.4M) | 32.8K | 1.8M | 11.2M |
| D&A | 4.9K | 5.6K | 10.2K | 32.8K | 24.7K |
| EBIT | (10.5M) | (14.4M) | 22.6K | 1.8M | 11.2M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026